Identifying Risk Factors for Regional Recurrence in Early-Stage Breast Cancer with pT1-2 and Negative Sentinel Lymph Node Biopsy

BACKGROUND: Due to the low rate of regional recurrence (RR) in early-stage breast cancer with pT1-2 and negative sentinel lymph node biopsy (SLNB), no regional therapy is suggested for them. However, whether there is a subset of patients who were with high risk of regional failure and may benefit fr...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Kai-yun, Bi, Zhuo-fei, Ding, Lin, Ma, Yu-jia, Liu, Yi-min, Yao, He-rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533902/
https://www.ncbi.nlm.nih.gov/pubmed/33061612
http://dx.doi.org/10.2147/CMAR.S264267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533902/
https://www.ncbi.nlm.nih.gov/pubmed/33061612
http://dx.doi.org/10.2147/CMAR.S264267

Ejemplares similares